Episode
A conversation with Kristen Ogden, patient advocate for Dr. David Bockoff
We speak with Miss Kristen Ogden, patient advocate and newly minted legal expert who has filed the first motion to ...
Analyzing opioid prescribing trends with Mr. Jacob James Rich
We speak with Mr. Jacob James Rich, who wrote an article in Reason Magazine - The Fight To Criminalize Opioid ...
A conversation with Dr. John Whyte, author of Take Control of Your Heart Disease Risk
Dr. Whyte is a three time author and the chief medical officer of WebMD. We discuss his latest book, Take ...
Catching up with Dr. Linda Cheek, founder of Doctors of Courage
We catch up with Dr. Linda Cheek to glean her thoughts on the DEA's continuing encroachment into healthcare in a ...
A conversation with Dr. Radhika Sharma, physician influencer and life coach
Dr. Sharma is an Obstetrics & Gynecology specialist and a Physician Life Coach, as well as a Personal Coach. She ...
A conversation with Dr. Alin Gragossian, physician and heart transplant survivor
Dr. Gragossian is a dual board certified physician specializing in Emergency Medicine & Critical Care Medicine. But her journey as ...
A conversation with Dr. Kyle Fischer, emergency medicine physician and gun policy expert
Kyle Fischer, MD, MPH, serves as the policy director for the Health Alliance for Violence Intervention. He leads the organization ...
A conversation with Dr. Selwyn Rogers, trauma surgeon and gun policy expert
Selwyn O. Rogers Jr., MD, MPH, FACS, is a widely respected surgeon and public health expert. As founding director of ...
A conversation with Dr. Jeffrey Singer, Cato Institute health policy expert
Dr. Jeffrey Singer is a senior fellow at the Cato Institute and works in the Department of Health Policy Studies. ...
A conversation with Dr. Leah Houston, founder of HPEC
Dr. Houston is an emergency medicine physician and a physician entrepreneur with a strong social media presence. She is a ...
A conversation with Dr. Nneka Unachukwu, founder of the EntreMD method
Dr. Unachukwu is the bestselling author of the EntreMD Method, host of the EntreMD Podcast and member of the Forbes ...
A conversation with Dr. Neil Anand, champion of physician rights
Dr. Anand is an Anesthesiologist and former Marine who found himself at the crossroads of the government's misguided approach to ...
BIIB080 in Mild Alzheimer’s Disease: What a Phase 1b Exploratory Clinical Analysis Can—and Cannot—Tell Us
Can lowering tau biology translate into a clinically meaningful slowing of decline in people with early symptomatic Alzheimer’s disease? That is the practical question behind BIIB080, an intrathecal antisense therapy designed to reduce production of tau protein by targeting the tau gene transcript. In a phase 1b program originally designed for safety and dosing, investigators later examined cognitive, functional, and global outcomes as exploratory endpoints. The clinical question matters because current disease-modifying options primarily target amyloid, while tau pathology tracks...
Read more